Genomics

Dataset Information

0

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.


ABSTRACT: Cytokine genes are targets of multiple epigenetic mechanisms in T lymphocytes. 5-azacytidine (5-azaC) is a nucleoside-based DNA methyltransferases (DNMT) inhibitor which induces demethylation and gene reactivation. In the current study, we analyzed the effect of 5-azaC in T-cell function and observed that 5-azaC inhibits T-cell proliferation and activation, blocking cell cycle in G0-G1 phase and decreasing the production of proinflammatory cytokines such as TNFα and IFNγ. This effect was not due to a pro-apoptotic effect of the drug but to the down-regulation of genes involved in T-cell cycle progression and activation such as CCNG2, MTCP1, CD58, and ADK and up-regulation of genes which induce cell growth arrest, such as DCUN1D2, U2AF2, GADD45B or p53. In spite of being also up-regulated, we did not find any effect of 5-azaC on the methylation pattern of FOXP3. Finally, the administration of 5-azaC at 60 and 84 hours post-transplant prevented the development of GVHD leading to a significant increase in survival in a fully mismatched BMT mouse model. In conclusion, the current study shows the effect of 5-azaC in T-lymphocytes and illustrates its role in the allogeneic transplantation setting as an immunomodulatory drug, describing new pathways which must be explored in order to prevent graft-versus-host disease.

ORGANISM(S): Homo sapiens

PROVIDER: GSE17922 | GEO | 2009/09/02

SECONDARY ACCESSION(S): PRJNA119883

REPOSITORIES: GEO

Similar Datasets

2016-12-23 | GSE92841 | GEO
| E-GEOD-62919 | biostudies-arrayexpress
| E-GEOD-62920 | biostudies-arrayexpress
| E-MTAB-5380 | biostudies-arrayexpress
| PRJNA428470 | ENA
2017-07-12 | GSE101126 | GEO
| E-GEOD-62922 | biostudies-arrayexpress
2022-09-19 | PXD031455 | Pride
2019-01-16 | GSE98911 | GEO
2022-12-21 | GSE202082 | GEO